Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05602623 · ClinicalTrials.gov registry record · NA
Characterizing the Intraocular Scattering at Different Wavelengths
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05602623 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 31 participants.
The verdict
NCT05602623, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a single-site, unmasked, 4-visit, randomized 3x3 cross-over clinical trial to quantify intraocular light scatter in different age groups.
Interventions
- DEVICE Adaptive Optics System (AO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-05-25 |
| Est. Completion | 2024-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05602623
The ClinicalTrials.gov registry entry for NCT05602623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adaptive Optics System (AO) is the first listed.
NCT05602623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05602623 about?
NCT05602623 is a clinical study titled "Characterizing the Intraocular Scattering at Different Wavelengths". This is a single-site, unmasked, 4-visit, randomized 3x3 cross-over clinical trial to quantify intraocular light scatter in different age groups.
What is the current status of trial NCT05602623?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-05-25. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT05602623?
The interventions under investigation include: Adaptive Optics System (AO) (DEVICE).
Who is sponsoring clinical trial NCT05602623?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.